Community

For Meda, responsible entrepreneurship also means contributing positively to the community. As a pharmaceutical company, Meda can improve people’s health and well-being by providing cost-effective and medically well-motivated drugs. Besides contributions generated by the company’s operations, Meda works actively in a range of community support projects, including donations to charitable organizations and research sponsorship.

Meda's children's fund

Meda’s Children’s Fund is a charitable foundation for needy children. It has been active since 2002, and supports a range of projects, such as (i) establishment of a child and prenatal care clinic in Ghana in collaboration with Plan International and Ghana’s health authority, (ii) a hospital project in Uganda, (iii) projects targeting victims of the tsunami disaster, and (iv) several school projects in Africa, some in collaboration with International Care and Relief (ICR). ICR is a UK-based relief organization with focus on Africa.

Karloniska Institutet

Karolinska Institutet’s Breakthroughs for Life campaign concerns research related to inflammatory diseases. In February 2008, Meda initiated a donation to the campaign, which will total SEK 35 million. Inflammatory diseases are one of Meda’s key therapy areas. Karolinska Institutet plays a critical role in the progress toward these conditions being preventable and curable in the future thanks to its state of-the-art research, completely new approaches to prevention and early treatment, and its unique close ties between basic and patient-based research.

Karolinska Institutet was founded in 1810 and is one of the world’s leading medical universities and one of the largest in Europe. It is Sweden’s only university with a purely medical focus and is the nation’s largest center for medical training and research. The Nobel Forum at Karolinska Institutet selects the Nobel laureates in physiology or medicine. The Breakthroughs for Life campaign aims to support research areas in which Karolinska Institutet is already a leader and in which financial measures can contribute to medical research breakthroughs in coming years.

AmeriCares

Since 2003, Meda has been a partner of AmeriCares, a non-profit organization that delivers medicine, medical supplies, and aid to needy people worldwide.

Since it was founded in 1982 at the request of Pope John Paul II, the organization has supplied humanitarian aid worth more than USD 9 billion to 137 countries. AmeriCares has provided aid after cyclones in Bangladesh, earthquakes in Peru and Pakistan, hurricane Katrina in the US, starvation in Darfur, and the tsunami in southeast Asia.

MAP International

Since 2001, Meda has donated drugs to MAP International, a non-profit aid organization founded in 1954. MAP works to provide clinics and hospitals in vulnerable areas with FDA-approved medicines and health-care equipment. MAP also works to prevent and mitigate outbreaks of disease and to promote construction of local health-care facilities. MAP works for the poorest people in more than 115 countries worldwide.

MAP has played a key role in providing access to healthcare and medicine for millions of victims of the most recent humanitarian disasters, such as starvation in Darfur, the tsunami in southeast Asia, and the devastating hurricane seasons in the Caribbean. In 2009 Meda donated medicine to Haiti, Honduras, Mongolia, Nicaragua, Romania, and many other developing countries.

Direct Relief International

In 2009, Meda donated pharmaceutical products to Direct Relief. Since 1948, Direct Relief International has helped people in extremely difficult situations to improve their quality of life. Direct Relief supports charitable health services by donating high-demand medicines, prescription drugs, medical supplies and equipment, personal care products, and nutritional supplements, as well as by providing targeted capital donations and health worker education.